The objective of this report is to provide timely information regarding the status of opioids including novel opioids and fentanyl analog prevalence, positivity, and discovery within the United States (NPS)
Bibliography: Domestic Policy Issues
ACT Pill Testing Trial 2019 (PDF)
Program evaluation (Australian National University)
Needle Syringe Program National Minimum Data Collection Report 2019
The Needle Syringe Program National Minimum Data Collection (NSP NMDC) supports the National Strategies for blood borne and sexually transmissible infections and complements the annual Australian Needle Syringe Program Survey National Data Report (The Kirby Institute, Australia)
Cannabis-based medicinal products (PDF)
This position statement examines the existing evidence on CBMPs and how they relate to mental health (RC PSYCH, UK)
My world survey: national study of youth mental health in Ireland (PDF)
Large-scale studies that capture the mental health profile of young people help us to understand their experiences and inform service provision. To date, there is a limited body of research on the prevalence of mental health difficulties among young people aged 12-25, particularly in the Irish context (UCD School of Psychology and Headstrong, Ireland)
Circular 009/2019: third generation synthetic cannabinoids update
Amendment to the generic definition of a group of synthetic cannabinoids (‘third generation’) under the Misuse of Drugs Act 1971, Misuse of Drugs Regulations 2001 and the Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015 (UK Government)
Toolkit containing strategies to prevent drug-related deaths in Scotland updated
A resource containing strategies to reduce drug-related deaths in Scotland has been updated and re-launched by Scottish Drugs Forum
Substance misuse treatment for adults: statistics 2018 to 2019
Statistics on alcohol and drug misuse treatment for adults from PHE’s National Drug Treatment Monitoring System (NDTMS)
National Drug Treatment Reporting System 2012-2018 drug data.
Health Research Board. (2019) National Drug Treatment Reporting System 2012-2018 drug data. Dublin: Health Research Board
Scottish Affairs Committee calls for decriminalisation and safe drug consumption rooms
The Scottish Affairs Committee publishes its report on Problem Drug Use in Scotland
Drugs policy
UK Parliament
Australian Drug Trends 2019: Key Findings from the Illicit Drug Reporting System (IDRS) Interviews
In 2019, we have provided a suite of products with the most up-to-date findings from interviews conducted annually from 2000-2019 with a cross-sectional sentinel group of people who regularly inject drugs recruited from all capital cities of Australia (NDARC)
Cannabis Legalization: Year One Observations
Provides the first summary of Canada’s experience in the first year of retail sales after cannabis legalization, with a focus on the public health and safety objectives of the Cannabis Act. Canada’s relationship with legal cann bis is evolving and the market is still developing (CCSA)
Government response to ACMD report ‘Ageing cohort of drug users’
Officials from each of the 4 nations have reviewed the Council’s advice carefully and set out work underway to address each of the recommendations below (Department of Health & Social Care)
Health matters: rough sleeping
This edition of Health Matters focuses on the scale of rough sleeping in England, the causes and consequences of rough sleeping (including the links with poor physical and mental health, prevention and effective interventions) and relevant calls to action (Public Health England)
Is the UK ready for drug policy reform? (PDF)
The Conservative Drug Policy Reform Group
Is the UK ready for drug policy reform? (PDF)
The Conservative Drug Policy Reform Group (CDPRG) exists to educate and inform the debate around drug policy reform. We are here to act as a forum where all parts of the debate can interact based on the evidence
Drugs policy and medicinal cannabis report: government response
The government’s response to the Health and Social Care Committee’s report
CDC Awards New Funds to Stop Drug Overdoses, Deaths
As the drug overdose crisis evolves and becomes more complex, the Centers for Disease Control and Prevention (CDC) is providing $301 million in new Overdose Data to Action funds to states and jurisdictions
Briefing paper: Opioids in the UK
Opioid related deaths in England and Wales are considerably higher than the OECD average. Addressing opioid dependence, misuse and overdoses in the UK requires policy coordination across health, social and criminal justice systems (CDPRG)
- 1
- 2
- 3
- …
- 16
- Next Page »
